title: Injectable Contraceptive Continuation among Female Exotic Dancers Seeking Mobile Reproductive Health Services.
abstract: OBJECTIVE
  We describe depot medroxyprogesterone acetate (DMPA) continuation patterns among female exotic dancers receiving reproductive health services at a mobile syringe exchange.
  
  
  METHODS
  Clients initiating DMPA between November 2009 and August 2012 were identified retrospectively via chart review. Life table analysis measured continuation. Client characteristics were compared using chi-square tests.
  
  
  RESULTS
  Sixty nine clients were identified; 72% were African American and 63% were younger than 25. At three months, 36% of the study sample continued DMPA; those continuing were more likely to be White (p=0.01) and receive other services (p=.01). The 12-month cumulative continuation probability was 0.09. Considering those who had received an injection, continuation proportions were higher (46% at 6; 71% at 12 months).
  
  
  CONCLUSIONS
  A subset of female exotic dancers may favor DMPA as a long term contraceptive. Integrating mobile reproductive health services into public health programs can help fulfill the unique health needs of this high-risk population.
authors.forename: Caitlin E
authors.initials: CE
authors.lastname: Martin
authors.forename: Jennifer J
authors.initials: JJ
authors.lastname: Han
authors.forename: Chris
authors.initials: C
authors.lastname: Serio-Chapman
authors.forename: Patrick
authors.initials: P
authors.lastname: Chaulk
authors.forename: Mishka
authors.initials: M
authors.lastname: Terplan
mesh_terms: D000293:Adolescent; D000328:Adult; D015142:Baltimore; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003615:Dancing; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage*; D008952:Mobile Health Units; D010342:Patient Acceptance of Health Care; D034121:Reproductive Health Services; D055815:Young Adult
chemical_list: D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate